A quantitative review of the ubiquitous relapse curve
- 31 January 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Substance Abuse Treatment
- Vol. 36 (1), 8-17
- https://doi.org/10.1016/j.jsat.2008.04.001
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous MelanomaJournal of Clinical Oncology, 2007
- Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant MelanomaJournal of Clinical Oncology, 2004
- Smoking cessation with and without assistance: A population-based analysisAmerican Journal of Preventive Medicine, 2000
- Initial abstinence and success in achieving longer term cocaine abstinence.Experimental and Clinical Psychopharmacology, 2000
- What is a relapse? Fifty ways to leave the wagonAddiction, 1996
- Replication and extension of Marlatt's taxonomy of relapse precipitants: overview of procedures and resultsAddiction, 1996
- Assessment issues and domains in the prediction of relapseAddiction, 1996
- Telephone counseling for smoking cessation: Effects of single-session and multiple-session interventions.Journal of Consulting and Clinical Psychology, 1996
- Measures of affect and nicotine dependence predict differential response to smoking cessation treatments.Journal of Consulting and Clinical Psychology, 1992
- Understanding and preventing relapse.American Psychologist, 1986